Clinical Trial Update: Lipid Metabolic Status in Thyroid Carcinoma

View source ↗

Summary

This clinical trial (NCT01487057) on lipid metabolic status in thyroid carcinoma has completed. It includes aspects related to dyslipidemias and associated mana…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Thyroid Carcinoma

Snippet

Sponsor: Prof. Dr. I. Chiricuta Institute of Oncology | Conditions: Thyroid Carcinoma, Dyslipidemias | Status: COMPLETED